Series B - BlackThorn Therapeutics
Investment Firm
Overview
BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.
Announced Date
Jun 13, 2019
Closed on Date
Jun 13, 2019
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
9
Round Details and Background
BlackThorn Therapeutics raised $76000000 on 2019-06-13 in Series B
BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 13, 2019 |  Series B - BlackThorn Therapeutics | 11 | - | 76.0M |
| Jun 20, 2017 | Grant - BlackThorn Therapeutics | 1 | - | 8.0M |
| Jan 05, 2017 | Series A - BlackThorn Therapeutics | 2 | - | 14.0M |
| Oct 20, 2016 | Series A - BlackThorn Therapeutics | 5 | - | 40.0M |
Recent Activity
There is no recent news or activity for this profile.